SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000318154-13-000008
Filing Date
2013-08-06
Accepted
2013-08-06 17:10:01
Documents
9
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q amgn-2013630x10q.htm 10-Q 1513459
2 RULE 13A-14(A) CERTIFICATIONS amgn-ex31_2013630xq2.htm EX-31 24263
3 SECTION 1350 CERTIFICATIONS amgn-ex32_2013630xq2.htm EX-32 10859
  Complete submission text file 0000318154-13-000008.txt   14602318

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT amgn-20130630.xml EX-101.INS 2071865
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amgn-20130630.xsd EX-101.SCH 50767
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amgn-20130630_cal.xml EX-101.CAL 80329
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amgn-20130630_def.xml EX-101.DEF 203822
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amgn-20130630_lab.xml EX-101.LAB 595150
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amgn-20130630_pre.xml EX-101.PRE 345217
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-12477 | Film No.: 131014361
SIC: 2836 Biological Products, (No Diagnostic Substances)